THYE DIRK (Chief Executive Officer) purchased 28.5% of their position (80K shares) of QUINCE THERAPEUTICS, INC. on the open market
Open‑market purchase worth $99.2K — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 8/9/2023ACC: 0001209191-23-045235
DirectorOfficer· Chief Executive Officer
Since May 2022
+80K
Net shares
Net buyer
$99.2K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
80K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+80K
Price / share
$1.24
Trade value
$99.20K
% of position
28.5%
8/8/2023
280.91K→360.91K
Total
Net shares
+80K
Net value
$99.20K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/8/2023 | P · Purchase | +80K | $1.24 | $99.20K | 28.5% | 280.91K | 360.91K |
| Total | +80K | $99.20K | ||||||
Derivative Transactions0
No derivative transactions reported